A school-based program for control of group a streptococcal upper respiratory tract infections: a controlled trial in Southern China.
A prospective, school-based study included daily monitoring for incidence of symptomatic streptococcal-associated pharyngitis and monthly determinations of group A streptococcal prevalence. A treatment group received penicillin/erythromycin therapy at school for positive throat cultures; the control group sought medical care from their regular provider. Prevalence and incidence of group A streptococcal pharyngitis were significantly lower among the treatment group than in the controls.
Lin
Shuguang
S
Rheumatic Fever Laboratory and the Division of Epidemiology, Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangzhou, Guangdong Province, Peoples' Republic of China.
Kaplan
Edward L
EL
Rao
Xuxu
X
Johnson
Dwight R
DR
Deng
Mulan
M
Zhuo
Qiling
Q
Yang
Pingzhen
P
Mai
Jinzhuang
J
Dong
Taiming
T
Liu
Xiaoqing
X
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002353:Carrier State / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D002648:Child; D002681:China / Q000453:epidemiology; D003695:Delivery of Health Care / Q000379:methods; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D010612:Pharyngitis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D010614:Pharynx / Q000382:microbiology; D015995:Prevalence; D015397:Program Evaluation; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D012574:Schools / Q000706:statistics & numerical data; D013290:Streptococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000302:isolation & purification; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D010406:Penicillins; D004917:Erythromycin